tpan.com: Test Positive Aware Network
Home
Discontinued by manufacturer in February 2006. See Invirase page.

Brand Name: Fortovase

Common Name: saquinavir soft-gel

Class: HIV protease inhibitor (PI)

Standard dose: Six 200 mg soft-gel capsules three times a day with food, or within two hours after a meal; or five 200 mg Fortovase with 100 mg Norvir, twice-a-day with food. Take missed dose as soon as possible, but do not double up on your next dose.

AWP: $263.35 / month

Manufacturer contact: Roche Pharmaceuticals, www.fortovase.com, 1 (800) 282–7780

AIDS Treatment Information Service: 1 (800) HIV–0440 (448–0440)

Potential side effects and toxicity: Most common include diarrhea, nausea, stomach pain, gas, indigestion, vomiting, headaches, insomnia, fatigue, body aches, anxiety, depression and taste alteration.

As seen with all other protease inhibitors are increased levels of cholesterol and triglycerides, except possibly unboosted Reyataz (atazanavir) and these increased levels may be associated with heart disease. Other possible side effects are lipodystrophy (body fat changes, including thinning of the face, arms and legs, with or without fat accumulation in the stomach, breasts and sometimes the upper back), onset of new cases or worsening of diabetes (see your doctor promptly) and increased bleeding in hemophiliacs.

Potential drug interactions: Do not take with Tambocor (flecainide), Rythmol (propafenone), Versed, Halcion, Hismanol, Seldane, rifampin, ergot derivatives (such as Cafergot, Wigraine and Methergine, D.H.E. 45, in any form—serious interactions seen with dilation during gynecological exams), garlic supplements, or the herb St. John’s wort. Do not use Zocor (simvastatin) or Mevacor (lovastatin); lipid-lowering alternatives are Lipitor (atorvastatin), Lescol, and Pravachol (pravastatin), but they should be used with caution due to potential for liver toxicity. Rifampin and Fortovase should not be used together.

Increased blood levels when taken with Crixivan, Norvir and Viracept. Blood levels are decreased significantly by Sustiva and Viramune, but can be taken together if Norvir is included. Other drugs that may also reduce Fortovase blood levels are Decadron and Tegretol, Dilantin, and phenobarbital. High incidence of liver problems, and severe ones, when taken with Rescriptor. The side effects of calcium channel blockers, clindamycin, dapsone and quinidine may be increased if taken with saquinavir.

Protease inhibitors increase blood levels of Viagra (sidenafil citrate), Cialis (tadalafil) and Levitra (vardenafil). Use with caution. Initially the Viagra dose should be 12.5 mg (1/2 of 25 mg tablet) and increased as needed and tolerated. It’s recommended that people on PIs do not exceed 25 mg of Viagra in a 48-hour period because of potential for serious reaction. Use Cialis at reduced doses of 10 mg every 72 hours and Levitra at reduced doses of no more than 2.5 mg every 72 hours, with increased monitoring for adverse events.

Tips: Due to decreased demand, will be taken off the market in February 2006. Switching to its original formulation, Invirase, is matched milligram for milligram. For example, five 200 mg Fortovase (1,000 mg) equals two 500 mg Invirase (1,000 mg). Must be taken with food or within two hours after a meal. Keep capsules at room temperature if they will be used up within three months. Zantac, Pepcid, Tagamet or antacids may be necessary to treat Fortovase heartburn (which is common). Refrigerated (36–46° F or 2–8° C) capsules remain stable until the expiration date printed on the manufacturer’s bottle. Once brought to room temperature capsules should be used within 3 months. Avoid direct sunlight. Dosings of Fortovase boosted with Norvir—five 200 mg Fortovase with one 100 mg Norvir twice-a-day or eight 200 mg Fortovase with one 100 mg Norvir once-a-day or five 200 mg Fortovase with three 133 mg Kaletra (lopinavir/ritonavir) twice-a-day.


Doctor

No statement.


Activist

No need to say anything, since it’s going off the market in early 2006.—Nelson Vergel


More Publications
Positively Aware Positively Aware
Positively Aware en Espanol Positively Aware en Español
HIV Drug Guide HIV Drug Guide
Chicago HIV Services Directory Chicago HIV Services Directory
Subscribe Subscribe
Advertise Advertise
Editorial Policy Editorial Policy
   
More Links
Access the PA Archive Access the PA Archive
Download Acrobat Reader from Adobe Download Acrobat Reader from Adobe
Download Acrobat Reader from Adobe
Search TPAN or the Web Using Google Search TPAN or the Web Using Google
 
   
 

Ask a physician questions you may have about HIV/AIDS, and HIV/AIDS treatment. An American Academy of HIV Medicine (AAHIVM) credentialed HIV Specialist will answer your questions. A new column regularly featured in Positively Aware magazine, in collaboration with the AAHIVM, beginning with the March/April 2007 issue.

Send your questions in care of
Ask the HIV Specialist
5537 N. Broadway
Chicago, IL 60640
E-mail: aahivm@tpan.com.

 

This site contains HIV prevention messages that may not be appropriate for all audiences. Since HIV infection is spread primarily through sexual practices or by sharing needles, prevention messages and programs may address these topics. If you are not seeking such information or may be offended by such materials, please exit this website.

Este sitio del web contiene mensajes de la prevención del VIH que pueden no ser appropiados para todas las audiencias. Puesto que la infección del VIH es propagada sobre todo con prácticas sexuales o por compartiendo jeringas, los mensajes y los programas de la prevención pueden dirigirse a estos asuntos. Si usted no está buscando tal información o puede ser ofendido por tales materiales, salga por favor de este website.

 
 

Opinions expressed in Positively Aware, Positively Aware en Español, or tpan.com are not necessarily those of staff or membership of Test Positive Aware Network (TPAN), its supporters and sponsors, or distributing agencies. Information, resources, and advertising in Positively Aware, Positively Aware en Español, or tpan.com do not constitute endorsement or recommendation of any medical treatment or product.

TPAN recommends that all medical treatments or products be discussed thoroughly and frankly with a licensed and fully HIV-informed medical practitioner, preferably a personal physician.

Although Positively Aware, Positively Aware en Español, and tpan.com take great care to ensure the accuracy of all the information that it presents, Positively Aware, Positively Aware en Español, and tpan.com staff and volunteers, TPAN, or the institutions and personnel who provide us with information cannot be held responsible for any damages, direct or consequential, that arise from use of this material or due to errors contained herein.

 
 
[an error occurred while processing this directive]
Home   | About TPAN   | Publications   | Client Services   | Events   | Online Directory   | Resources   | Contact Us